semaglutide or tirzepatide as Compared with for the Treatment of Obesity Tirzepatide vs Semaglutide | Best

ESC Guidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases Developed in Collaboration With the EASD

Furthermore FFAR2 activation in vivo with an inulin-enriched diet in mice results in PYY release and proliferation of L cells in vitro ( in vivo involvement of FFAR2 and FFAR3 in GLP-1 modulation (301, 302), with some reports indicating that blockade of GPR43 in vitro releases GLP-1 (303) and others indicating different mechanisms of action, with FFAR2 releasing PYY from intestinal L-cells (295) despite its apparent expression by the majority of enteroendocrine cells ( In pancreatic -cells, both GPR43 and GPR41 are expressed, and the latter antagonizes GSIS (304)

It is not absorbed systemically and does not interact with semaglutide

And thats what makes GLP-1 screening so crucial

Evans, G